University Of Maryland, Baltimore
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1807-01-01
- Employees
- 7.3K
- Market Cap
- -
- Website
- http://www.umaryland.edu
Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
Phase 2
Terminated
- Conditions
- Shigella
- Interventions
- Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccineOther: Placebo
- First Posted Date
- 2009-03-20
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 20
- Registration Number
- NCT00866476
- Locations
- ๐บ๐ธ
University of Maryland, Baltimore Center for Vaccine Development, Baltimore, Maryland, United States
Safety of VSL#3 in Adult Asthmatics
Phase 1
Terminated
- Conditions
- Asthma
- Interventions
- Biological: VSL#3Biological: VSL#3 or placebo
- First Posted Date
- 2009-02-26
- Last Posted Date
- 2023-04-20
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 3
- Registration Number
- NCT00852124
- Locations
- ๐บ๐ธ
University of Maryland Baltimore, Baltimore, Maryland, United States
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
Early Phase 1
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Procedure: Hyperinsulinemic hyperglycemic glucose clampProcedure: euinsulinemic hyperglycemic glucose clampProcedure: euinsulinemic euglycemic glucose clampProcedure: Hyperinsulinemic euglycemic glucose clamp
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2019-09-12
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 31
- Registration Number
- NCT00829699
- Locations
- ๐บ๐ธ
Univerisity of Maryland, Baltimore, Baltimore, Maryland, United States
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
Phase 4
Completed
- Conditions
- Metabolic Syndrome
- Interventions
- First Posted Date
- 2009-01-09
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 15
- Registration Number
- NCT00819403
- Locations
- ๐บ๐ธ
VA Maryland Health Care System, Baltimore, Maryland, United States
๐บ๐ธUniversity of Maryland Medical Center, Baltimore, Maryland, United States
๐บ๐ธJohns Hopkins Hospital, Baltimore, Maryland, United States
A Safe Environment for Every Kid (SEEK): A Model for Primary Care
Not Applicable
Completed
- Conditions
- Child Maltreatment
- Interventions
- Other: Model Care
- First Posted Date
- 2009-01-09
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 905
- Registration Number
- NCT00819702
- Locations
- ๐บ๐ธ
University of Maryland, School of Medicine, Baltimore, Maryland, United States
Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516
Phase 1
Withdrawn
- Conditions
- Non-Small Cell Lung Cancer (NSCLC)
- Interventions
- Radiation: SBRT
- First Posted Date
- 2009-01-08
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT00818714
Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol
- First Posted Date
- 2008-12-10
- Last Posted Date
- 2022-02-25
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 15
- Registration Number
- NCT00806390
- Locations
- ๐บ๐ธ
University of Maryland, Baltimore, Maryland, United States
The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
Phase 2
Terminated
- Conditions
- Inflammatory Bowel DiseaseUlcerative Colitis
- Interventions
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2019-12-04
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 1
- Registration Number
- NCT00805285
- Locations
- ๐บ๐ธ
University of Maryland, Baltimore, Maryland, United States
Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
Phase 4
Completed
- Conditions
- Platelet Aggregation InhibitorsCoronary Heart Disease
- Interventions
- First Posted Date
- 2008-11-27
- Last Posted Date
- 2022-02-24
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 682
- Registration Number
- NCT00799396
- Locations
- ๐บ๐ธ
Amish Research Clinic, Lancaster, Pennsylvania, United States
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine
- First Posted Date
- 2008-10-27
- Last Posted Date
- 2019-09-12
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 56
- Registration Number
- NCT00780650
- Locations
- ๐บ๐ธ
Univerisity of Maryland, Baltimore, Baltimore, Maryland, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath